Jun 2, 2014
Study Shows Castle Biosciences' Gene Expression Profile Test...
Castle Biosciences Inc. today announced results of a 217-patient study demonstrating that its gene expression profile test, DecisionDx-Melanoma, identified primary cutaneous melanoma tumors that were sentinel lymph node biopsy negative but were at high risk of metastasis.
Cupertino girl among Spelling Bee finalists
Neha Konakalla, the 13-year-old speller from Cupertino, Calif., has reached the finals of the National Spelling Bee.
Three Company Founders Settle SEC Insider Trading Case
Most insider trading cases center on news about a corporate event such as an acquisition or an earnings announcement that has not become public.
Three Lawson Software founders settle SEC insider trading charges
Three Lawson Software Inc founders agreed to pay about $5.8 million to settle U.S. insider trading charges that they took advantage of incorrect media and analyst reports to trade stock ahead of the company's 2011 merger.